Krishna Institute of Medical Sciences Limited (NSE:KIMS)
660.35
+6.15 (0.94%)
Jun 6, 2025, 12:31 PM IST
NSE:KIMS Revenue
In the fiscal year ending March 31, 2025, Krishna Institute of Medical Sciences had annual revenue of 30.35B INR with 21.49% growth. Krishna Institute of Medical Sciences had revenue of 7.97B in the quarter ending March 31, 2025, with 25.73% growth.
Revenue
30.35B
Revenue Growth
+21.49%
P/S Ratio
8.62
Revenue / Employee
6.05M
Employees
5,013
Market Cap
261.77B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 30.35B | 5.37B | 21.49% |
Mar 31, 2024 | 24.98B | 3.00B | 13.67% |
Mar 31, 2023 | 21.98B | 5.47B | 33.13% |
Mar 31, 2022 | 16.51B | 3.21B | 24.13% |
Mar 31, 2021 | 13.30B | 2.07B | 18.46% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 271.45B |
Apollo Hospitals Enterprise | 217.94B |
Mankind Pharma | 122.07B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Alkem Laboratories | 129.65B |